RXi Pharmaceuticals names board member
Insight Weekly: US bank stress tests; cracks in housing market; summer energy supply risks
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
RXi Pharmaceuticals Corp. appointed Jonathan Freeman to its board as an independent director, with immediate effect.
Freeman also serves as the chief business officer of privately held Vedanta Biosciences.